CAR T and CAR NK cells in cancer treatment
Prof. Dr. Ulrike Koehl
Fraunhofer Institute
Cell Therapies: Shaping the Future of Medicine
Steve Rees
AstraZeneca
Commercializing cell and gene therapies: your path forward
Dr. Dirk Voelkel
Cytiva
Cell Therapy Panel Discussion
Steve Rees (AstraZeneca), Prof. Dr. Ulrike Koehl (Fraunhofer Institute), Dr. Dirk Voelkel (Cytiva), Dr. Mario Koksch (Beckman Coulter)
Improved methods for CRISPR HDR research using Alt-RTM modified donors and Alt-R HDR Enhancer V2
Dr. Garrett Rettig
Integrated DNA Technologie Inc.
Characterization of Adeno- Associated Viruses by Analytical Ultracentrifugation
Amy Henrickson
University of Lethbridge
Biophysical characterization in the context of C&G development
Dr. Alexander Bepperling
Novartis AG
Gene Therapy Panel discussion
Dr. Borries Demeler (University of Lethbridge), Dr. Alexander Bepperling (Novartis AG), Dr. Lutz Ehrhardt (Beckman Coulter)
Industrial biofoundries for organism breeding
Dr. Massimo Merighi
Lesaffre
Open Synthetic Biology - enabling research to impact world challenges
Dr. Ariel Linder
CRI-Centre de Recherche Interdisciplinaire
Alexis Casas
An initiative for distributed biofoundries to enable global collaborative worker
Imperial College London
Synthetic Biology Panel Discussion
Dr. Paul Freemont (Imperial College London) , Dr. Michael Krogh Jensen(Technical University of Denmark), Dr. Massimo Merighi (Lesaffre)